https://www.selleckchem.com/pr....oducts/cd38-inhibito
ssuring fetal status. In the unadjusted and adjusted analyses, there were no significant differences in the primary outcomes of psychomotor or mental developmental delay at 2 years of age (adjusted odds ratio, 0.96; confidence interval, 0.76-1.2. The only significant difference in secondary outcomes was a shorter O requirement duration in the parenteral opioid group (2 vs 4 days; P=.002). Among a population of preterm infants vulnerable to neurologic impairment, intrapartum exposure to parenteral opioids was not associated wi
Like
Comment
Share
